Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center.
Freund, Y.R., Akama, T., Alley, M.R., Antunes, J., Dong, C., Jarnagin, K., Kimura, R., Nieman, J.A., Maples, K.R., Plattner, J.J., Rock, F., Sharma, R., Singh, R., Sanders, V., Zhou, Y.(2012) FEBS Lett 586: 3410-3414
- PubMed: 22841723 
- DOI: https://doi.org/10.1016/j.febslet.2012.07.058
- Primary Citation of Related Structures:  
3O0J - PubMed Abstract: 
We have used boron-based molecules to create novel, competitive, reversible inhibitors of phosphodiesterase 4 (PDE4). The co-crystal structure reveals a binding configuration which is unique compared to classical catechol PDE4 inhibitors, with boron binding to the activated water in the bimetal center ...